Hinge Health, Inc.

Name: Hinge Health, Inc. standardized financial statements, quarterly
Creator: Listed

HNGENYSECIK 1673743TechnologyFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$212.8m, Q2 FY2026

Operating income$40.4m, Q2 FY2026

Net income$43.7m, Q2 FY2026

Hinge Health, Inc., income statement, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	not reported	89.8	101	117	124	139	154	171	182	213
Cost of revenue	$m	not reported	23.2	21.4	21.2	23.6	41.3	28.0	26.7	28.1	28.9
Gross profit	$m	not reported	66.6	79.3	96.1	100	97.8	126	144	154	184
Research and development	$m	not reported	24.9	23.8	22.4	23.5	280	31.9	32.8	30.3	34.1
Operating income	$m	not reported	(17.6)	(3.8)	20.9	13.1	(581)	(6.1)	27.3	32.1	40.4
Income tax	$m	not reported	0.4	1.1	(1.0)	1.0	(0.3)	0.2	0.1	0.8	0.7
Net income	$m	(26.5)	(12.9)	0.3	27.1	17.1	(576)	(1.8)	32.1	35.1	43.7
Diluted EPS	$ per share	not reported	(0.96)	0.01	not reported	1.31	(13.10)	(0.02)	not reported	0.41	0.52
Basic EPS	$ per share	not reported	(0.96)	0.01	not reported	7.91	(13.10)	(0.02)	not reported	0.43	0.55

Balance sheet

Cash and equivalents$286.2m, Q2 FY2026

Shareholders' equity$344.3m, Q2 FY2026

Hinge Health, Inc., balance sheet, quarterly
Line item	Unit	period not labelled2022-12-31	period not labelled2023-12-31	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	not reported	235	not reported	237	268	301	288	237	261	208	187	286
Current assets	$m	not reported	not reported	not reported	not reported	not reported	583	not reported	598	659	534	540	643
Total assets	$m	not reported	not reported	not reported	not reported	not reported	673	not reported	694	770	745	729	827
Current liabilities	$m	not reported	not reported	not reported	not reported	not reported	249	not reported	314	357	362	414	481
Total liabilities	$m	not reported	not reported	not reported	not reported	not reported	257	not reported	320	362	366	417	483
Shareholders' equity	$m	(318)	(424)	(450)	(463)	(462)	(435)	(308)	174	208	179	112	344

Cash flow

Operating cash flow$101.4m, Q2 FY2026

Capital expenditure$123.0k, Q2 FY2026

Share repurchases$26.5m, Q2 FY2026

Hinge Health, Inc., cash flow, quarterly
Line item	Unit	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	28.4	38.3	4.9	20.2	82.4	63.9	43.1	101
Capital expenditure	$m	0.3	0.2	0.1	0.2	0.1	0.4	0.1	0.1
Share repurchases	$m	not reported	not reported	0.0	0.0	not reported	not reported	105	26.5

Diluted shares (weighted)83.42m, Q2 FY2026

Hinge Health, Inc., shares, quarterly
Line item	Unit	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	13.5	16.6	92.7	43.9	78.9	82.4	83.4

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.

Hinge Health, Inc.

Income statement

Balance sheet

Cash flow

Shares